Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Other Accumulated Expenses (2020 - 2026)

Bio-Techne (TECH) posted quarterly Other Accumulated Expenses of $2.1 million for Q1 2026, up 15.39% year-over-year from $1.8 million in Q1 2025, and up 32.57% quarter-over-quarter from $1.6 million in Q4 2025.

Analysis

Bio-Techne (TECH) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

Bio-Techne's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses rose 15.39% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (up 15.39% YoY), while the FY2025 annual figure was $1.6 million, down 23.52% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $2.1 million, up from $1.6 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $4.5 million in Q3 2025, with the low at $865000.0 in Q1 2023.
  • The 5-year median for Other Accumulated Expenses is $2.1 million (2026), against an average of $2.5 million.
  • The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses sank 75.87% in 2022, then soared 240.92% in 2024.
  • Bio-Techne's Other Accumulated Expenses stood at $1.3 million in 2022, then surged by 220.32% to $4.2 million in 2023, then sank by 37.7% to $2.6 million in 2024, then tumbled by 40.05% to $1.6 million in 2025, then jumped by 32.57% to $2.1 million in 2026.
  • Business Quant data shows TECH's Other Accumulated Expenses at $2.1 million in Q1 2026, $1.6 million in Q4 2025, and $4.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.03 Mn
Mar 31, 2026 2.09 Mn
Dec 31, 2025 1.58 Mn
Sep 30, 2025 4.55 Mn
Jun 30, 2025 1.65 Mn
Mar 31, 2025 1.81 Mn
Dec 31, 2024 2.63 Mn
Sep 30, 2024 4.27 Mn
Jun 30, 2024 2.15 Mn
Mar 31, 2024 2.95 Mn
Dec 31, 2023 4.23 Mn
Sep 30, 2023 4.44 Mn
Jun 30, 2023 1.41 Mn
Mar 31, 2023 865,000.00
Dec 31, 2022 1.32 Mn
Sep 30, 2022 1.96 Mn
Jun 30, 2022 1.24 Mn
Mar 31, 2022 3.08 Mn
Dec 31, 2021 5.47 Mn
Sep 30, 2021 3.61 Mn